Pharvaris, a biopharmaceutical company based in Zug, Switzerland, announced the acceptance of multiple abstracts for presentation at three significant upcoming congresses focusing on angioedema, ...

William & Mary's Graduate Center invites graduate students conducting research in Humanities, Humanistic Social Sciences, and the Sciences to present at the upcoming Graduate Research Symposium.

BRISBANE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted ...

The presentation concerns MCLA-129 evaluated as monotherapy in patients with locally advanced/metastatic METex14 NSCLC. The abstracts will be available on the ASCO website on May 23, 2024 at 5:00 p.m.

Arbutus Biopharma Corporation announced that five abstracts, including a late-breaker, have been accepted for poster presentations at the EASL Congress 2025 in Amsterdam from May 7 to 10, 2025. The ...

You must submit your abstract using the online submission form. Abstracts sent by email will not be considered. Abstracts that are incomplete will not be considered. All ESA Annual Meeting proposal ...

Notably, Abstract #1 has been selected for presentation during the ABA Meeting’s Plenary for Top 5 Abstracts session and was selected for this special honor from over 500 abstracts submitted. This ...

A lightning talk is a very short presentation on a timely topic of interest to the audience. Lightning talks are 2-3 minutes with just 1-2 slides, followed by a group discussion. The main goals of the ...

NATICK, Mass.--(BUSINESS WIRE)--Naveris, Inc. announces the presentation of an abstract related to its flagship diagnostic test for TTMV-HPV DNA (NavDx ®) at the 2022 American Society of Clinical ...